GlobeX Data Ltd (CSE:SWIS) (OTCQB:SWISF) is close to launching its data protection platforms in the Bahamas, it said Monday. The Toronto- and New York-based company’s “Work From Home” services include GlobeX’s secure business cloud solutions package, comprised of the firm’s flagship DigitalSafe, PrivaTalk and Custodia technologies for secure communications. GlobeX will work with its exclusive reseller Sebastian Alliance Group in the Caribbean nation.
Royal Road Minerals Limited (CVE:RYR) is working to resume its mineral exploration in Colombia after the country’s Ministry of Mines put in place new health guidelines in a government circular allowing companies to proceed amid the coronavirus (COVID-19) pandemic. The company filed operating protocols related to the guidelines with Colombia’s national authorities. In addition to the country’s guidelines, Royal Road said it will also adhere to the guidance of IFC (World Bank Group) Performance Standards.
Weekend Unlimited Industries Inc (CSE:POT) (OTCQB:WKULF) agreed to settle around C$301,000 of outstanding debt by issuing just over 3.3 million shares of the company. The agreement with the cannabis company’s unnamed creditor was finalized on Monday, according to a statement. The Vancouver-based firm’s shares closed trading on Monday at C$0.125.
Gold Resource Corporation (NYSEAMERICAN:GORO) announced Monday it produced 10,142 ounces (oz) of gold and 407,625 (oz) of silver during the first three months of 2020. The gold and silver producer, developer and explorer runs operations in Oaxaca, Mexico and Nevada. In a statement, the company said results for the first-quarter ended March 31 showed that its Oaxaca Mining unit produced a total 6,450 ounces of gold, 402,542 ounces of silver, 488 tonnes of copper, 2,514 tonnes of lead and 5,844 tonnes of zinc. Preliminary 1Q production at its Nevada Mining Unit totaled 3,692 ounces of gold from the Isabella Pearl deposit’s lower variable grade Isabella zone.
Avalon GloboCare Corp (NASDAQ:AVCO) revealed that it has achieved “significant milestones” in advancing its immunotherapeutic AVA-Trap technology program towards combatting the cytokine storm associated with coronavirus (COVID-19) lung damage and mortality. It has been developing therapies for fighting cytokine storms long before it was linked to lung damage and death in coronavirus cases. Cell therapy-focused Avalon initiated a sponsored research and co-development project with the Massachusetts Institute of Technology (MIT), led by Professor Shuguang Zhang as principal investigator in May last year. The company said it has completed functional studies of six QTY code designed variant cytokine receptors as a “molecular mop” to remove excessive cytokines related to coronavirus infection and cellular immunotherapy.
Japan Gold Corp (CVE:JG) (OTCQB:JGLDF) announced Monday it is raising up to C$3 million to fund ongoing exploration in the Asian nation. The Vancouver-based company has a host of gold exploration properties across three of Japan’s largest islands and a country-wide alliance with mining giant Barrick Gold Corporation on its 30 projects. The private placement sees Japan Gold issuing up to 12 million units priced at C$0.25 per unit for gross proceeds of C$3 million.
Acasti Pharma Inc (NASDAQ:ACST) (CVE:ACST) told investors on Monday that it has further strengthened its intellectual property (IP) portfolio as it moves towards a potential launch of its drug CaPre, sending shares higher. The company is developing CaPre, a krill-oil derived prescription drug, to treat hypertriglyceridemia - high levels of triglycerides in the blood - which is known to contribute to heart disease. In a statement, the biotech said it has now been granted a second composition matter patent from the Canadian Intellectual Property office.
Naturally Splendid Enterprises Ltd (CVE:NSP) (OTCMKTS:NSPDF) announced Monday a non-brokered private placement financing to raise up to $1.5 million. The proceeds will be directed primarily towards the company's 100%-owned Prosnack Safe Quality Food Level 2 (SQF2) Certified food manufacturing facility, according to a statement. Under the placement, Naturally Splendid is offering up to 42,857,143 onits at a price of $0.035 apiece.
RNC Minerals Corp (TSE:RNX), the Western Australia focused miner, told investors it remained on track to achieve its gold production guidance for 2020 of between 90,000 and 95,000 ounces as it reported strong first quarter output. In the three months to March, the company said it generated 24,816 ounces of gold from the Beta Hunt and Higginsville mines. In a statement, the firm also said it expects to achieve its all-in-sustaining-cost (AISC) guidance of between US$1,050 and US$1,200 per ounce sold for 2020, assuming there is no significant interruption due to the coronavirus (COVID-19) pandemic.
InnoCan Pharma Corporation (CSE:INNO) has announced a tie-up with Tel Aviv University company Ramot in a bid to combat the deadly global spread of respiratory disease coronavirus (COVID-19). The firm's wholly-owned subsidiary InnoCan Pharma Ltd has struck a sponsored research agreement with Ramot to develop a novel, revolutionary approach to treat COVID-19 by using cannabidiol (CBD) loaded Exosomes (ICLX), InnoCan revealed in a statement. CBD-loaded Exosomes hold the potential to provide anti-inflammatory properties and help infected lung cells to recover.
XPhyto Therapeutics Corp (CSE:XPHY) (OTCPINK:XPHYF) said it is teaming up with a German biotech company to develop and commercialize oral screening tests for coronavirus (COVID-19). The agreement with 3a-Diagnostics GmbH will see the two companies work on an oral, dissolvable, thin-film screening tests that will rapidly detect infectious diseases.
Mawson Resources Ltd (TSE:MAW) (OTCMKTS:MWSNF) has reported more stellar drill results from its huge Rajapalot gold project in Finland and said it remained on track to deliver an updated resource at the start of the third quarter of 2020. In a statement, Mawson said it sunk 37 holes for 14,132 metres in the winter program, including one wedged drill hole and the deepening of an existing hole. It has reported results from 24 holes and 13 remain pending. Significantly, the firm said it had uncovered a new gold zone and that latest assays had continued to extend gold and cobalt mineralization beyond previously defined resources.
Co-Diagnostics Inc (NASDAQ:CODX) announced Monday that sales of its Logix Smart coronavirus (COVID-19) test have continued to increase in the US as individual states move to ramp up testing. The company said it has shipped tests to more than a dozen US states and has received orders from more than 50 countries since receiving an Emergency Use Authorization from the Food and Drug Administration (FDA) on April 3.
Loop Insights Inc (CVE:MTRX) has said it is launching a new contactless check-in platform for the healthcare sector in an effort to reduce the spread of bacteria and disease. Loop’s Smart Health platform requires just a tap on the patient’s mobile phone to check in and verify identification. Patients will have contactless access to everything they need in one wallet pass, such as real-time notifications, wait time updates and requisition information.
Mota Ventures Corp (CSE:MOTA) (OTCMKTS:PEMTF) announced Monday that demand for its CBD products helped it achieve significant revenue growth in March. In a statement, the e-commerce-focused company said its First Class CBD brand garnered sales of C$4,290,000, a 235% year-over-year increase, with related expenses of C$4,240,000.
Marrone Bio Innovations Inc (NASDAQ:MBII), a producer of biological products for crop protection and plant health, said its board has identified a “final candidate” for consideration after initiating a nationwide search for a new chief executive. The company announced in December last year that its founder Dr Pamela Marrone was retiring from her role as chief executive. Meanwhile, Kevin Hammill, who is the chief commercial officer at Marrone Bio, also told investors in a corporate update on Friday that sales of Marrone Bio's products in the specialty crop market have been positive year-to-date, despite February being “one of the driest months on record” in the company’s “key California market.”
Biocept Inc (NASDAQ:BIOC) is expanding uses for its flagship liquid biopsy Target Selector technology which detects cancer biomarkers. The San Diego-based company announced Monday the availability of research-use-only (RUO) Target Selector kits that will allow molecular laboratories globally to detect key oncogene mutations through the analysis of both Formalin-Fixed Paraffin-Embedded (FFPE) tissue gained from surgical biopsies as well as circulating tumor DNA (ctDNA) gained from blood-based liquid biopsies.
Aftermath Silver Ltd (CVE:AAG) (OCTMKTS:AAGF), a junior resource group with assets in Chile, has outlined first phase exploration plans for its Cachinal and Challacollo silver projects where it carried out site visits in the first week of March this year. In a statement, the firm also noted, however, that it could not currently mobilize people or equipment to the projects due to the coronavirus crisis.
NetCents Technology Inc (CSE:NC) (OTCMKTS:NTTCF) boss Clayton Moore has told investors that his firm is well-positioned to benefit from the current global coronavirus crisis as cryptocurrency and blockchain begin to reshape and alter future financial infrastructures. In a letter to shareholders, Moore said he believes the firm's advisory board will be instrumental in the 'tidal change that is about to begin' whereby all of global commercial banks will start to receive and manage cryptocurrency for clients.
CytoDyn Inc (OTCQB:CYDY) has named biotech entrepreneur Dr Samir Patel to its board of directors. Dr Patel’s appointment comes as the company advances its flagship drug candidate leronlimab in a Phase 2b/3 trial for severe and critical coronavirus (COVID-19) symptoms. In a statement Monday, CytoDyn noted that Dr Patel is an active entrepreneur serving as co-founder and CEO of Digital Therapeutics LLC, co-founder of SPEC Pharma LLC, a consultant for GE Global Research, and principal in PranaBio Investments LLC, which provides strategic advisory services for small-cap biotechnology companies.
Medgold Resources Corp (CVE:MED) (OTCMKTS:MGLDF), a gold exploration company targeting early-stage properties in the Balkan region, said Monday that it inked a letter of agreement with privately-held Gecon EOOD for an exploration license application made by it for the Zlogosh property, in Kyustendil Oblast, western Bulgaria. In a statement, Medgold said that the main mineralized targets at Zlogosh are situated approximately 40 kilometers by road from Medgold's Tlamino project in Serbia, with which they appear to “share considerable geological similarity.”
Tectonic Metals Inc. (CVE:TECT) announced that it has closed its C$2.1 million strategic financing with Doyon, Limited previously announced on April 15, 2020. Doyon is now Tectonic's largest, single shareholder with a 16.1% undiluted ownership and a 22.3% ownership on a partially diluted basis. It also said that Tectonic and Doyon are hosting a live webinar on Tuesday, April 21 at 11.00am EDT/8.00am PST, where the CEOs of both companies will be presenting and will be available to answer questions following the presentation. Online registration and participation details are available by clicking the following link: https://bit.ly/2xiiJS0. For those unable to participate, a recording of the webinar will be posted to the company's website, www.tectonicmetals.com, following the live broadcast.
Vendetta Mining Corp. (CVE:VTT) said it has received approval from the TSX Venture Exchange to amend the exercise price and expiry date of common share purchase warrants previously issued in connection with its non-brokered private placement of units that closed on June 3, 2019. The group said the warrants now have the same exercise price and expiry date as those issued pursuant to its non-brokered private placement of units that closed on July 30, 2019. Each Warrant initially entitled the holder to purchase one common share of the company at a price of $0.15 per common share until June 3, 2021, but have been amended to an exercise price of $0.13 each and expiry date of June 3, 2022. The company also announces that it has sought and received approval from the TSX Venture Exchange to reduce the price of its previously announced non-brokered private placement, announced on February 11, 2020, from $0.05 per unit to $0.04 per unit. The company will issue up to 13,750,000 units at the new price for gross proceeds of up to $550,000. Each Unit will be comprised of one common share and one common share purchase warrant exercisable for three years at a price of $0.06 per share. The net proceeds of the financing will primarily be used to maintain the Issuer's existing operations, activities, and advance the development of the Pegmont Lead-Zinc project.
Silver Range Resources Ltd. (CVE:SNG) has announced that, in the interest of preserving its working capital in these uncertain times, it has amended its "Shares for Services Agreement" with Paladin Geoscience Corp., a private company controlled by Michael A. Power, Silver Range's president and chief executive officer. Under the amended agreement, Paladin, which provides geological and other consulting services to Silver Range, will now receive a minimum of 50% and, at Paladin's sole discretion, up to a maximum of 100% of its monthly consulting fee by the issuance of Silver Range common shares. All shares will be issued at a deemed price per share equal to the market price of Silver Range's shares calculated at the end of each month in which such services are provided minus 50% of the discount permitted under applicable Exchange policies. The shares will be issued semi-annually and will be subject to a four-month and one day hold period commencing upon the date of issuance. Any consulting fees not paid for by the issuance of Silver Range shares will be paid in cash, the group added.
Dyadic International, Inc. (NASDAQ:DYAI) a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to speed up the development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales, has said it will be presenting at the Planet MicroCap Showcase 2020 on Wednesday, April 22 at 12:40pm Eastern Time. The group said its CEO Mark Emalfarb will be hosting the presentation and answering questions from investors. The live presentation webcast will be available at: https://www.webcaster4.com/Webcast/Page/2059/34175. In addition to the company webcast, Dyadic will also be participating in a virtual panel titled, "Potential Solutions for Addressing the Coronavirus Pandemic", hosted by John Vandermosten, Senior Biotech Analyst at Zack's Small Cap Research, on Tuesday, April 21, 2020. This can be accessed at: https://www.webcaster4.com/Webcast/Page/2059/34212
AgraFlora Organics International Inc (CSE:AGRA) (OTCMKTS:AGFAF) said that, as a result of the coronavirus (COVID-19) pandemic, it will be relying on the co-ordinated relief provided by the securities regulators, which consists of a 45-day extension for certain periodic filings, as announced by the Canadian Securities Administrators (CSA) on March 18. The company said it is continuing to work with its auditor to file its annual filings by June 15. AgraFlora confirmed that there have been no material developments, other than those disclosed through news releases, since the filing of its condensed interim consolidated financial statements for the period ended September 30, 2019.